Review of central venous disease in hemodialysis patients

Area of Science:

• Vascular Surgery
• Nephrology
• Interventional Cardiology

Background:

• Central venous occlusive disease is a prevalent complication in patients undergoing hemodialysis.
• Existing treatments such as angioplasty, bare metal stents, and surgical bypass have limitations due to poor long-term patency.
• This necessitates repeated interventions, increasing patient morbidity and healthcare costs.

Purpose of the Study:

• To review the current treatment options for central venous occlusive disease in hemodialysis patients.
• To evaluate the emerging role of covered stents in managing central venous stenosis and obstruction.
• To highlight the need for further research, including randomized controlled trials, to compare treatment efficacy.

Main Methods:

• Literature review of existing treatments for central venous occlusive disease.
• Discussion of the preliminary data and potential of covered stents.
• Emphasis on the importance of preventative strategies for central venous access.

Main Results:

• Current treatments like angioplasty and bare metal stents offer suboptimal long-term patency.
• Covered stents represent a newer therapeutic option with limited but emerging data.
• Preventative measures to limit central venous interventions are crucial.

Conclusions:

• Central venous occlusive disease management in hemodialysis patients remains challenging.
• Covered stents show potential but require robust comparative studies against established methods.
• Prioritizing prevention of central venous access issues is essential for long-term patient outcomes.